LMR-31125-16994
4 vaccinations
1 coded response
20 check-ins
1 free-text entry
1 call case
- Sex
- Male
- Age at first dose
- 05-11
- ZIP prefix
- 015 / MA
- Registered
- 2021-12-08
- Relationship
- Child or adolescent in my care
- Guardian
- 2X8-40539-43287
- Race
- Multiracial
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-12-07
Dose 1 — Pfizer-BioNTech
-
2021-12-08
Registered in v-safe
-
2021-12-08
Health check-in — days 1–6 daily, dose 1, dependentFeeling: Fair · Site: Pain, Itching · Headache, Fatigue or tiredness, Abdominal painAdult check-in
- 2021-12-13
-
2021-12-28
Dose 2 — Pfizer-BioNTech
-
2021-12-31
Health check-in — days 1–6 daily, dose 2, dependentFeeling: Poor · Fever · Fatigue or tiredness, Nausea, Vomiting · Be unable to do your normal daily activitiesAdult check-in
- 2022-01-02
- 2022-01-06
- 2022-01-14
- 2022-01-18
- 2022-01-25
- 2022-02-03
- 2022-02-10
-
2022-07-15
Dose 3 — Pfizer-BioNTech
-
2022-11-20
Dose 4 — Pfizer-BioNTechCo-administered: Flu
-
2022-11-21
Health check-in — days 1–6 daily, dose 4, dependentFeeling: Fair · Site: Pain · Chills, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
- 2022-11-26
- 2022-11-27
- 2022-12-06
- 2022-12-11
- 2022-12-20
-
2022-12-27
Survey response — day 35, dose 4, dependentMedDRA: Conjunctivitis — Feeling: Good · Be unable to work or attend school, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Pink eyeMedDRA releases: 2024-11 · check-in free text available
-
2022-12-27
Report sent to call center — day 35, dose 4, dependentBe unable to work or attend school · Get care from a doctor or other healthcare professionalTelehealth, virtual health, or email health consultation · 1 call case(s)
- 2022-12-28
- 2023-01-01
- 2023-02-19
- 2023-05-23
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-12-07 | Pfizer-BioNTech | No |
| 2 | 2021-12-28 | Pfizer-BioNTech | No |
| 3 | 2022-07-15 | Pfizer-BioNTech | No |
| 4 | 2022-11-20 | Pfizer-BioNTech | Flu |
Call center
1 call center case
1 unsuccessful
Free text
Release 12 — day 35, dose 4, dependent
Symptoms: Pink eye
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Conjunctivitis | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release